Treatment of mice with methamphetamine produces cell loss in the substantia nigra

Brain Research
P K SonsallaE D Hall

Abstract

Studies were conducted to determine if treatment of mice with methamphetamine (METH) would produce a loss of dopaminergic cells in the substantia nigra. The number of TH+/Nissl-stained was significantly decreased in both Swiss-Webster (S-W) and C57bl mice (approx. cell loss of 40% and 45%, respectively) 5-8 days after treatment with METH. In these same mice there was a corresponding decrease in neostriatal dopamine (DA) content (90% and 92%, respectively). In parallel studies, treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produced similar neuropathological effects. The finding that nigral cell loss occurs after METH treatment indicates that the METH-treated mouse may be a very relevant model of Parkinson's disease (PD).

Citations

May 12, 2007·Addiction·John F MarshallSteven J O'Dell
Dec 11, 2013·Molecular Neurobiology·Ramavati PalSimon Geir Møller
Dec 9, 2014·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Armanda Teixeira-GomesJoão Paulo Capela
Jun 6, 2009·Expert Review of Proteomics·Christopher C ParkDesmond J Smith
Apr 23, 2013·Journal of Internal Medicine·S Ares-SantosR Moratalla
Jan 8, 2015·Frontiers in Neuroanatomy·Javier Blesa, Serge Przedborski
Jul 23, 2003·Journal of Neurochemistry·Giuseppe BattagliaAntonio De Blasi
Dec 3, 2003·Brain : a Journal of Neurology·Anna MoszczynskaStephen J Kish
Jan 19, 2010·Pharmacological Reports : PR·Bessy ThrashMuralikrishnan Dhanasekaran
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Erwan Bezard, Serge Przedborski
Oct 31, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sara Ares-SantosRosario Moratalla
Mar 12, 2013·Parkinson's Disease·Noelia GranadoRosario Moratalla
Mar 1, 2017·Archives of Pharmacal Research·Eun-Joo ShinHyoung-Chun Kim
Aug 2, 2003·Journal of Pharmacological Sciences·Taizo KitaToshikatsu Nakashima
Jun 11, 2004·Journal of Neurochemistry·Anna MireckiStephen J Kish
Jul 4, 2007·Journal of Attention Disorders·Claire Advokat
Mar 6, 2010·Annals of the New York Academy of Sciences·Bryan K YamamotoGary A Gudelsky
Oct 11, 2013·Movement Disorders : Official Journal of the Movement Disorder Society·Giulia CostaMicaela Morelli
Mar 31, 2019·International Journal of Molecular Sciences·Giulia CostaMicaela Morelli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Related Papers

Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Dong-dong LiZhe-hui Feng
Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology
Yue LiYi-ping Sun
© 2021 Meta ULC. All rights reserved